These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 36270495)

  • 21. Five-year mortality and readmission rates in patients with heart failure in India: Results from the Trivandrum heart failure registry.
    Harikrishnan S; Jeemon P; Ganapathi S; Agarwal A; Viswanathan S; Sreedharan M; Vijayaraghavan G; Bahuleyan CG; Biju R; Nair T; Pratapkumar N; Krishnakumar K; Rajalekshmi N; Suresh K; Huffman MD
    Int J Cardiol; 2021 Mar; 326():139-143. PubMed ID: 33049297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Virtual optimization of guideline-directed medical therapy in hospitalized patients with heart failure with reduced ejection fraction: the IMPLEMENT-HF pilot study.
    Bhatt AS; Varshney AS; Nekoui M; Moscone A; Cunningham JW; Jering KS; Patel PN; Sinnenberg LE; Bernier TD; Buckley LF; Cook BM; Dempsey J; Kelly J; Knowles DM; Lupi K; Malloy R; Matta LS; Rhoten MN; Sharma K; Snyder CA; Ting C; McElrath EE; Amato MG; Alobaidly M; Ulbricht CE; Choudhry NK; Adler DS; Vaduganathan M
    Eur J Heart Fail; 2021 Jul; 23(7):1191-1201. PubMed ID: 33768599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of and association between heart failure pharmacological treatments and outcomes in obese versus non-obese patients with heart failure with reduced ejection fraction: data from the Swedish Heart Failure Registry.
    Cappelletto C; Stolfo D; Orsini N; Benson L; Rodolico D; Rosano GMC; Dahlström U; Sinagra G; Lund LH; Savarese G
    Eur J Heart Fail; 2023 May; 25(5):698-710. PubMed ID: 36781199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Supra-normal and mildly reduced ejection fraction in women -An overlooked vulnerable subpopulation in heart failure.
    Kawai A; Nagatomo Y; Yukino-Iwashita M; Ikegami Y; Takei M; Goda A; Kohno T; Mizuno A; Kitamura M; Nakano S; Sakamoto M; Shiraishi Y; Kohsaka S; Adachi T; Yoshikawa T;
    Int J Cardiol; 2024 Aug; 409():132166. PubMed ID: 38744340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guideline-directed medical therapy in elderly patients with heart failure with reduced ejection fraction: a cohort study.
    Seo WW; Park JJ; Park HA; Cho HJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
    BMJ Open; 2020 Feb; 10(2):e030514. PubMed ID: 32034017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low blood pressure and guideline-directed medical therapy in patients with heart failure with reduced ejection fraction.
    Izumi K; Kohno T; Goda A; Takeuchi S; Shiraishi Y; Saji M; Nagatomo Y; Tanaka TD; Takei M; Nakano S; Soejima K; Kohsaka S; Yoshikawa T;
    Int J Cardiol; 2023 Jan; 370():255-262. PubMed ID: 36270494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of Guideline-Directed Medical Therapy in Heart Failure Patients With and Without Chronic Kidney Disease: A Meta-Analysis of 63,677 Patients.
    Clark KM; Mahboob F; Evans J; Sun JH; Wang N
    Heart Lung Circ; 2024 Mar; 33(3):281-291. PubMed ID: 38365495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guideline-directed medical therapy in patients undergoing transcatheter edge-to-edge repair for secondary mitral regurgitation.
    Higuchi S; Orban M; Adamo M; Giannini C; Melica B; Karam N; Praz F; Kalbacher D; Koell B; Stolz L; Braun D; Näbauer M; Wild M; Doldi P; Neuss M; Butter C; Kassar M; Ruf T; Petrescu A; Ludwig S; Pfister R; Iliadis C; Unterhuber M; Sampaio F; Ferreira D; Thiele H; Baldus S; von Bardeleben RS; Massberg S; Windecker S; Lurz P; Petronio AS; Lindenfeld J; Abraham WT; Metra M; Hausleiter J;
    Eur J Heart Fail; 2022 Nov; 24(11):2152-2161. PubMed ID: 35791663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Guideline Directed Medical Therapy Doses and Optimization in Patients Hospitalized With Decompensated Systolic Heart Failure.
    Grewal D; Partow-Navid R; Garcia D; Coney J; Fraser G; Stoletniy L; Sakr A; Parwani P; Abramov D
    Am J Cardiol; 2021 Jul; 151():64-69. PubMed ID: 34167690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guideline-Directed Medical Therapy and Survival Following Hospitalization in Patients with Heart Failure.
    Tran RH; Aldemerdash A; Chang P; Sueta CA; Kaufman B; Asafu-Adjei J; Vardeny O; Daubert E; Alburikan KA; Kucharska-Newton AM; Stearns SC; Rodgers JE
    Pharmacotherapy; 2018 Apr; 38(4):406-416. PubMed ID: 29423950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Racial Differences in Trends and Prognosis of Guideline-Directed Medical Therapy for Heart Failure with Reduced Ejection Fraction: the Atherosclerosis Risk in Communities (ARIC) Surveillance Study.
    Mathews L; Ding N; Sang Y; Loehr LR; Shin JI; Punjabi NM; Bertoni AG; Crews DC; Rosamond WD; Coresh J; Ndumele CE; Matsushita K; Chang PP
    J Racial Ethn Health Disparities; 2023 Feb; 10(1):118-129. PubMed ID: 35001343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heart rate, beta-blocker use, and outcomes of heart failure with reduced ejection fraction.
    Ibrahim NE; Gaggin HK; Turchin A; Patel HK; Song Y; Trebnick A; Doros G; Maya JF; Cannon CP; Januzzi JL
    Eur Heart J Cardiovasc Pharmacother; 2019 Jan; 5(1):3-11. PubMed ID: 29490032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mortality and guideline-directed medical therapy in real-world heart failure patients with reduced ejection fraction.
    McCullough PA; Mehta HS; Barker CM; Van Houten J; Mollenkopf S; Gunnarsson C; Ryan M; Cork DP
    Clin Cardiol; 2021 Sep; 44(9):1192-1198. PubMed ID: 34342033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guideline-Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction and Incident Cancer.
    Tini G; Tanda S; Toma M; Battistoni A; Musumeci B; Barbato E; Canepa M; Ameri P
    Heart Lung Circ; 2024 May; 33(5):704-709. PubMed ID: 38609799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of kidney function on guideline-directed medical therapy implementation and prognosis in heart failure with reduced ejection fraction.
    Bánfi-Bacsárdi F; Pilecky D; Vámos M; Majoros Z; Török GM; Borsányi TD; Dékány M; Solymossi B; Andréka P; Duray GZ; Kiss RG; Nyolczas N; Muk B
    Clin Cardiol; 2024 Feb; 47(2):e24244. PubMed ID: 38402552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electronic Alerts to Improve Heart Failure Therapy in Outpatient Practice: A Cluster Randomized Trial.
    Ghazi L; Yamamoto Y; Riello RJ; Coronel-Moreno C; Martin M; O'Connor KD; Simonov M; Huang J; Olufade T; McDermott J; Dhar R; Inzucchi SE; Velazquez EJ; Wilson FP; Desai NR; Ahmad T
    J Am Coll Cardiol; 2022 Jun; 79(22):2203-2213. PubMed ID: 35385798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Remote Optimization of Guideline-Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction.
    Desai AS; Maclean T; Blood AJ; Bosque-Hamilton J; Dunning J; Fischer C; Fera L; Smith KV; Wagholikar K; Zelle D; Gaziano T; Plutzky J; Scirica B; MacRae CA
    JAMA Cardiol; 2020 Dec; 5(12):1430-1434. PubMed ID: 32936209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The independent reduction in mortality associated with guideline-directed medical therapy in patients with coronary artery disease and heart failure with reduced ejection fraction.
    Wolfe NK; Mitchell JD; Brown DL
    Eur Heart J Qual Care Clin Outcomes; 2021 Jul; 7(4):416-421. PubMed ID: 32324852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A scoring evaluation for the practical introduction of guideline-directed medical therapy in heart failure patients.
    Matsukawa R; Okahara A; Tokutome M; Itonaga J; Koga E; Hara A; Kisanuki H; Sada M; Okabe K; Kawai S; Ogawa K; Matsuura H; Mukai Y
    ESC Heart Fail; 2023 Dec; 10(6):3352-3363. PubMed ID: 37671603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment Differences in Medical Therapy for Heart Failure With Reduced Ejection Fraction Between Sociodemographic Groups.
    Witting C; Zheng J; Tisdale RL; Shannon E; Kohsaka S; Lewis EF; Heidenreich P; Sandhu A
    JACC Heart Fail; 2023 Feb; 11(2):161-172. PubMed ID: 36647925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.